Print Page     Close Window     

Due to legal restrictions, only residents of Australia and New Zealand may access ASX announcements that contain information or materials relating to any capital raising.



Keyword Search
 
2018 | 2017
DateTitle 
13 December 2018Meetings Held With FDA Support MSB's Planned GVHD Filing
... 
Download PDF
05 December 2018Response to ASX query
... 
Download PDF
30 November 2018Results of Meeting
... 
Download PDF
30 November 2018Presentation to 2018 Annual General Meeting
... 
Download PDF
30 November 2018Chairman's Address to Shareholders
... 
Download PDF
26 November 2018Tasly and MSB Initiate Activities For MPC-150-IM In China
... 
Download PDF
16 November 2018MSB Provides Q1 Financial Results and Operational Highlights
... 
Download PDF
16 November 2018First Quarter Results Presentation
... 
Download PDF
16 November 2018First Quarter Financial Results on Form 6-K
... 
Download PDF
13 November 2018LVAD Results Webcast Presentation
... 
Download PDF
12 November 2018LVAD Trial Results Provide Potential Regulatory Pathway
... 
Download PDF
12 November 2018Pause in Trading
... 
Download PDF
09 November 2018MSB To Host Webcast For Heart Failure Results At AHA
... 
Download PDF
31 October 2018Appendix 4C - quarterly
... 
Download PDF
30 October 2018Annual Report to shareholders
... 
Download PDF
30 October 2018Notice of General Meeting/Proxy Form
... 
Download PDF
30 October 2018Appendix 4G and Corporate Governance Statement
... 
Download PDF
25 October 2018GVHD and CHF Updates to Emerging Leaders Conference
... 
Download PDF
24 October 2018MSB Expands Partnership With JCR For Skin Disease
... 
Download PDF
16 October 2018Change in substantial holding
... 
Download PDF
12 October 2018Completion of Tasly Transaction, and Appendix 3B
... 
Download PDF
11 October 2018Release of shares from voluntary escrow
... 
Download PDF
02 October 2018End-Stage HF Results Selected For AHA Scientific Sessions
... 
Download PDF
25 September 2018Mesoblast Cardiac Cell Therapy In Children
... 
Download PDF
20 September 2018Day 180 Survival Outcomes In aGvHD Phase 3 Trial
... 
Download PDF
17 September 2018Tasly Receives Approvals For Transaction With MSB
... 
Download PDF
30 August 2018Mesoblast Reports on Annual and Fourth Quarter Results
... 
Download PDF
30 August 2018Annual Financial Results Presentation
... 
Download PDF
30 August 2018Preliminary Final Report including Appendix 4E
... 
Download PDF
29 August 2018UPDATE ON TASLY TRANSACTION
... 
Download PDF
31 July 2018Appendix 4C - quarterly
... 
Download PDF
18 July 2018Initial Director's Interest Notice
... 
Download PDF
17 July 2018MSB Enters Into Cardiovascular Alliance For China With Tasly
... 
Download PDF
11 July 2018Director Appointment/Resignation
... 
Download PDF
10 July 2018Appendix 3B
... 
Download PDF
02 July 2018MSB Enters Into US$50M Financing With NovaQuest Capital
... 
Download PDF
25 June 2018Initial and Final Directors' Interest Notices
... 
Download PDF
22 June 2018ISSCR Presentation on P3 GVHD Trial Survival Benefits
... 
Download PDF
21 June 2018Key Day 100 Survival Results In P3 GvHD Trial
... 
Download PDF
19 June 2018Director Appointment/Resignation
... 
Download PDF
31 May 2018MSB Provides Q3 Financial Results and Operational Highlights
... 
Download PDF
31 May 2018Mesoblast Appoints New Chief Financial Officer
... 
Download PDF
31 May 2018Third Quarter Results Presentation
... 
Download PDF
31 May 2018Third Quarter Financial Results on Form 6-K
... 
Download PDF
29 May 2018Partnership For Allogeneic Cell-based Cancer Immunotherapies
... 
Download PDF
15 May 2018Cleansing notice and Appendix 3B
... 
Download PDF
08 May 2018MSB P3 Results For GVHD Presented At ISCT Meeting
... 
Download PDF
01 May 2018MSB Cell Therapies Featured At Vatican Healthcare Conference
... 
Download PDF
30 April 2018Appendix 4C - quarterly
... 
Download PDF
18 April 2018MSB Clinical Program Update For MPC-150-IM In Heart Failure
... 
Download PDF
29 March 2018Mesoblast Phase 3 CLBP Trial Completes Enrollment
... 
Download PDF
09 March 2018Change in substantial holding
... 
Download PDF
07 March 2018MSB Enters Into $75 Million Non-Dilutive Credit Facility
... 
Download PDF
28 February 2018Mesoblast Provides Half Year Results and Corporate Update
... 
Download PDF
28 February 2018Half Year Results Presentation
... 
Download PDF
28 February 2018Half Year Report and Accounts (including Appendix 4D)
... 
Download PDF
23 February 2018GVHD Day 28 Results Presentation
... 
Download PDF
22 February 2018Primary Endpoint Successfully Achieved in MSB P3 GVHD Trial
... 
Download PDF
31 January 2018Appendix 4C - quarterly
... 
Download PDF
19 January 2018Appendix 3B with prospectus
... 
Download PDF
12 January 2018Presentation to J.P. Morgan 2018 Healthcare Conference
... 
Download PDF
11 January 2018Presentation at JP Morgan Healthcare Conference
... 
Download PDF

Copyright © 2015 Mesoblast Inc.